Equities

Adventa Bhd

ADVENTA:KLS

Adventa Bhd

Actions
Health CareMedical Equipment and Services
  • Price (MYR)0.270
  • Today's Change-0.005 / -1.82%
  • Shares traded89.90k
  • 1 Year change-12.90%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Adventa Berhad is a Malaysia-based company, which is engaged in investment holding and provision of management services. The Company's segments include Healthcare and Corporate. The healthcare business segment comprises the supply of healthcare and related products and services to hospitals, healthcare centers and pharmacies. Its subsidiaries include Adventa Healthcare Sdn. Bhd., Nextech Med Pte. Ltd., PT Adventa Biotech International (PT Adventa Biotech), Mycare Lanka (Private) Limited and others. Adventa Healthcare Sdn. Bhd. is engaged in the distribution of medical and healthcare equipment, appliances, and medical disposal products. Nextech Med Pte. Ltd. is an investment holding company.

  • Revenue in MYR (TTM)42.74m
  • Net income in MYR-5.07m
  • Incorporated2003
  • Employees1.11k
  • Location
    Adventa BhdNo 21, Jalan Tandang 51/205A, Seksyen 51PETALING JAYA 46050MalaysiaMYS
  • Phone+60 392130520
  • Fax+60 377729821
  • Websitehttps://www.adventa.com.my/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
LKL International Bhd44.06m-8.52m42.69m225.006.700.2634--0.96880.01640.01640.08980.41760.23122.084.39195,832.00-4.46---4.88--31.21---19.30--2.27-3.700.1318--------------
Adventa Bhd42.74m-5.07m84.03m1.11k--0.8967--1.97-0.0351-0.03510.18330.30670.4646--1.47---5.57-2.71-6.31-3.64--17.76-12.00-4.442.15-104.590.0377---36.78---76.53------
One Glove Group Bhd27.62m-41.47m114.60m220.00--1.10--4.15-0.0775-0.07750.04730.19130.0542.153.70125,537.50-8.12---10.31---81.14---150.40--0.7595-5.150.5717--------------
Iconic Worldwide Bhd39.67m-113.87m168.71m442.00--0.9486--4.25-0.1021-0.10210.05110.10540.13241.365.94---38.01---43.44---25.75---287.05--1.17-6.710.3566--------------
Careplus Group Bhd84.72m-26.10m187.95m2.90k--0.6186--2.22-0.0443-0.04430.14030.40410.2334.045.23---7.60---8.88---24.94---32.60--1.67-7.740.1439--------------
Hextar Healthcare Bhd156.72m-57.71m208.84m806.00--0.33--1.33-0.0576-0.05760.15620.53030.25571.291.52---9.428.22-10.009.3737.7055.05-36.8214.133.67-84.600.0099---11.55-5.49-15.61---22.15--
UMediC Group Bhd54.57m8.99m224.35m--24.973.1219.034.110.0240.0240.14590.19250.69982.363.32--11.9212.3912.8215.2341.5438.4917.0316.115.8294.000.0119--20.1127.15-12.8846.792.69--
Sancy Bhd-100.00bn-100.00bn237.71m----------------0.0352----------------------------0.0148--11.50--367.47------
Comfort Gloves Bhd289.87m-20.75m244.84m1.70k--0.285310.770.8447-0.0358-0.03580.50071.470.30073.174.36---2.1511.17-2.3913.181.7924.88-7.1613.253.89--0.0511---46.28-7.2212.98---26.11--
Data as of Nov 22 2024. Currency figures normalised to Adventa Bhd's reporting currency: Malaysian Ringgit MYR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.